Compare ELWT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELWT | INCR |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 50.4M |
| IPO Year | N/A | 2021 |
| Metric | ELWT | INCR |
|---|---|---|
| Price | $6.89 | $0.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 54.6K | 27.3K |
| Earning Date | 05-15-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $167.76 | $69.54 |
| Revenue Next Year | $22.42 | $41.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.11 | $0.68 |
| 52 Week High | $8.25 | $1.77 |
| Indicator | ELWT | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 31.36 |
| Support Level | $6.11 | $0.72 |
| Resistance Level | $7.05 | $0.88 |
| Average True Range (ATR) | 0.71 | 0.04 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 54.56 | 21.00 |
Elauwit Connection Inc is a customer-centric service provider of broadband Internet networks for the multifamily and student housing property sectors across the United States. The company generates revenue from the following sources: network design and installation and internet network services. It provides service offering wholesale to REITs, property ownership groups, and property management companies, engaged in its target real estate sectors.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.